These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 7544046)
1. Analysis of human immunodeficiency virus type 1 integrase mutants. Ansari-Lari MA; Donehower LA; Gibbs RA Virology; 1995 Aug; 211(1):332-5. PubMed ID: 7544046 [TBL] [Abstract][Full Text] [Related]
2. Mutations in the protease gene of human immunodeficiency virus type 1 affect release and stability of virus particles. Park J; Morrow CD Virology; 1993 Jun; 194(2):843-50. PubMed ID: 8503189 [TBL] [Abstract][Full Text] [Related]
3. Multiple effects of mutations in human immunodeficiency virus type 1 integrase on viral replication. Engelman A; Englund G; Orenstein JM; Martin MA; Craigie R J Virol; 1995 May; 69(5):2729-36. PubMed ID: 7535863 [TBL] [Abstract][Full Text] [Related]
4. Characterization of gag and pol sequences from long-term survivors of human immunodeficiency virus type 1 infection. Huang Y; Zhang L; Ho DD Virology; 1998 Jan; 240(1):36-49. PubMed ID: 9448687 [TBL] [Abstract][Full Text] [Related]
5. Human immunodeficiency virus type 1 integrase stabilizes a linearized HIV-1 LTR plasmid in vivo. Faust EA; Acel A; Udashkin B; Wainberg MA Biochem Mol Biol Int; 1995 Jul; 36(4):745-58. PubMed ID: 8528137 [TBL] [Abstract][Full Text] [Related]
6. Characterization of human immunodeficiency virus type 1 Pr160 gag-pol mutants with truncations downstream of the protease domain. Liao WH; Wang CT Virology; 2004 Nov; 329(1):180-8. PubMed ID: 15476885 [TBL] [Abstract][Full Text] [Related]
7. Analysis of protein expression and virus-like particle formation in mammalian cell lines stably expressing HIV-1 gag and env gene products with or without active HIV proteinase. Kräusslich HG; Ochsenbauer C; Traenckner AM; Mergener K; Fäcke M; Gelderblom HR; Bosch V Virology; 1993 Feb; 192(2):605-17. PubMed ID: 8421902 [TBL] [Abstract][Full Text] [Related]
8. Overexpression of the HIV-1 gag-pol polyprotein results in intracellular activation of HIV-1 protease and inhibition of assembly and budding of virus-like particles. Karacostas V; Wolffe EJ; Nagashima K; Gonda MA; Moss B Virology; 1993 Apr; 193(2):661-71. PubMed ID: 7681610 [TBL] [Abstract][Full Text] [Related]
9. Analysis of human immunodeficiency virus type 1 integrase mutants. Ansari-Lari MA; Donehower LA; Gibbs RA Virology; 1995 Nov; 213(2):680. PubMed ID: 7491794 [No Abstract] [Full Text] [Related]
10. A drug resistance mutation in the inhibitor binding pocket of human immunodeficiency virus type 1 reverse transcriptase impairs DNA synthesis and RNA degradation. Fan N; Rank KB; Slade DE; Poppe SM; Evans DB; Kopta LA; Olmsted RA; Thomas RC; Tarpley WG; Sharma SK Biochemistry; 1996 Jul; 35(30):9737-45. PubMed ID: 8703945 [TBL] [Abstract][Full Text] [Related]
11. A human cell line constitutively expressing HIV-1 Gag and Gag-Pol gene products. Wang CT; Li JJ; Lai HY; Hu BS J Med Virol; 1999 Jan; 57(1):17-24. PubMed ID: 9890417 [TBL] [Abstract][Full Text] [Related]
12. Natural variation in HIV-1 protease, Gag p7 and p6, and protease cleavage sites within gag/pol polyproteins: amino acid substitutions in the absence of protease inhibitors in mothers and children infected by human immunodeficiency virus type 1. Barrie KA; Perez EE; Lamers SL; Farmerie WG; Dunn BM; Sleasman JW; Goodenow MM Virology; 1996 May; 219(2):407-16. PubMed ID: 8638406 [TBL] [Abstract][Full Text] [Related]
13. Genetic analysis of human immunodeficiency virus type 1 integrase and the U3 att site: unusual phenotype of mutants in the zinc finger-like domain. Masuda T; Planelles V; Krogstad P; Chen IS J Virol; 1995 Nov; 69(11):6687-96. PubMed ID: 7474078 [TBL] [Abstract][Full Text] [Related]
14. Decreasing the frameshift efficiency translates into an equivalent reduction of the replication of the human immunodeficiency virus type 1. Dulude D; Berchiche YA; Gendron K; Brakier-Gingras L; Heveker N Virology; 2006 Feb; 345(1):127-36. PubMed ID: 16256163 [TBL] [Abstract][Full Text] [Related]
15. Mason-Pfizer monkey virus (MPMV) constitutive transport element (CTE) functions in a position-dependent manner. Rizvi TA; Schmidt RD; Lew KA Virology; 1997 Sep; 236(1):118-29. PubMed ID: 9299624 [TBL] [Abstract][Full Text] [Related]
16. Extensive regions of pol are required for efficient human immunodeficiency virus polyprotein processing and particle maturation. Quillent C; Borman AM; Paulous S; Dauguet C; Clavel F Virology; 1996 May; 219(1):29-36. PubMed ID: 8623542 [TBL] [Abstract][Full Text] [Related]
17. Restriction of HIV-1 replication in intestinal cells is genetically controlled by the gag-pol region of the HIV-1 genome. De Mareuil J; Guettari N; Bolmont C; Salaun D; Baillon JG; Hostomsky Z; Hirsch I Virology; 1995 Feb; 207(1):160-7. PubMed ID: 7532883 [TBL] [Abstract][Full Text] [Related]
18. Tat is required for efficient HIV-1 reverse transcription. Harrich D; Ulich C; García-Martínez LF; Gaynor RB EMBO J; 1997 Mar; 16(6):1224-35. PubMed ID: 9135139 [TBL] [Abstract][Full Text] [Related]
19. Antiretroviral agents as inhibitors of both human immunodeficiency virus type 1 integrase and protease. Mazumder A; Wang S; Neamati N; Nicklaus M; Sunder S; Chen J; Milne GW; Rice WG; Burke TR; Pommier Y J Med Chem; 1996 Jun; 39(13):2472-81. PubMed ID: 8691444 [TBL] [Abstract][Full Text] [Related]
20. Naturally occurring amino acid polymorphisms in human immunodeficiency virus type 1 (HIV-1) Gag p7(NC) and the C-cleavage site impact Gag-Pol processing by HIV-1 protease. Goodenow MM; Bloom G; Rose SL; Pomeroy SM; O'Brien PO; Perez EE; Sleasman JW; Dunn BM Virology; 2002 Jan; 292(1):137-49. PubMed ID: 11878916 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]